“…Gene expression profiles have been used to classify tumours (Bittner et al, 2000;Ramaswamy et al, 2001;Selaru et al, 2002;Shipp et al, 2002), study the biology of tumour progression and metastasis (Birkenkamp-Demtroder et al, 2002;Ramaswamy et al, 2003), predict clinical outcomes Huang et al, 2003;Iizuka et al, 2003), classify drug resistance (Hofmann et al, 2002;Chang et al, 2003) and identify novel drug targets (Marton et al, 1998). As the technology matures, it is pushing towards mainstream clinical application (Gershon, 2004;Jarvis and Centola, 2005;Cardoso et al, 2008).…”